Regulus Therapeutics Inc. is a biopharmaceutical company leading the discovery of a new class of high-impact medicines based on microRNAs. MicroRNAs are small non-coding RNAs...
Dr. Noam Shomron. Group Leader and Head Genome High-throughput sequencing laboratory Department of Cell and Developmental Biology, Sackler Faculty of Medicine, Tel Aviv University. Israel....
Regulus Therapeutics Inc. is a biopharmaceutical company leading the discovery of a new class of high-impact medicines based on microRNAs. MicroRNAs are small non-coding RNAs...
Cancer biologist Andrea Ventura explains how his lab uses genetically engineered mouse models to understand how cancer works, why we get cancer, and how his...
David Baltimore, PhD, delivers a talk on MicroRNAs in Inflammation and Cancer, one of a series of lectures from The Yale School of Medicine Bicentennial...
Dr Andrea Ventura, of the Memorial Sloan-Kettering Cancer Center in the USA, talks about the potential of microRNAs as novel therapeutic targets in cancer treatment...
